Skip to main content
Premium Trial:

Request an Annual Quote

BD, Accelr8 Reach Bacterial Dx Development Agreement with License Option

NEW YORK (GenomeWeb News) – Becton Dickinson has solidified an agreement to fund a research program at Accelr8 for rapid bacterial diagnostics, Accelr8 said today.
 
The agreement supports a program running through September 2009, and includes an option that would allow BD to exclusively license Accelr8’s infectious disease diagnostics IP, while Accelr8 would retain the right to commercialize the technology for other applications. If BD exercises that option it will pay an initial fee as well as royalties, and it would be responsible for meeting certain commercialization requirements.
 
BD will fund all product development, manufacturing, and marketing conducted under the license, Accelr8 said.
 
As GenomeWeb Daily News reported in December, Becton Dickinson agreed to pay $100,000 for the right to negotiate with Accelr8 through March 31, 2008, for the new development agreement, and the companies reached an agreement in principle on April 1.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.